A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Glaucoma is an irreversible condition resulting from the increase in intraocular pressure (IOP); which leads to permanent loss of vision with the destruction of retinal ganglion cells (RGCs). The IOP elevations are controlled in normal by the physiological flow of aqueous humour. A population with a...
Guardado en:
Autores principales: | Maneesha Peter, Rajitha Panonnummal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4866cba9126d4958a246d2eb9fd64f5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical Medication Therapy for Glaucoma and Ocular Hypertension
por: Tao Wang, et al.
Publicado: (2021) -
Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
por: Helen Humphries, et al.
Publicado: (2021) -
Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes RA, et al.
Publicado: (2019) -
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies M, et al.
Publicado: (2016) -
The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
por: Poelman HJ, et al.
Publicado: (2020)